JPS5643448B1 - - Google Patents
Info
- Publication number
- JPS5643448B1 JPS5643448B1 JP2321371A JP2321371A JPS5643448B1 JP S5643448 B1 JPS5643448 B1 JP S5643448B1 JP 2321371 A JP2321371 A JP 2321371A JP 2321371 A JP2321371 A JP 2321371A JP S5643448 B1 JPS5643448 B1 JP S5643448B1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fastening Of Light Sources Or Lamp Holders (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB36270/67A GB1242211A (en) | 1967-08-08 | 1967-08-08 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5643448B1 true JPS5643448B1 (ja) | 1981-10-13 |
Family
ID=10386572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2321371A Pending JPS5643448B1 (ja) | 1967-08-08 | 1971-04-14 |
Country Status (14)
Country | Link |
---|---|
US (1) | US3634582A (ja) |
JP (1) | JPS5643448B1 (ja) |
BE (1) | BE718846A (ja) |
CA (1) | CA946280A (ja) |
DE (2) | DE1792207C3 (ja) |
DK (1) | DK123276B (ja) |
FI (1) | FI48973C (ja) |
FR (2) | FR8142M (ja) |
GB (1) | GB1242211A (ja) |
IE (1) | IE32343B1 (ja) |
MY (2) | MY7400329A (ja) |
NL (1) | NL161984C (ja) |
NO (1) | NO128307B (ja) |
SE (1) | SE372420B (ja) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006516531A (ja) * | 2002-08-21 | 2006-07-06 | ノートン ヘルスケアー リミテッド | 吸入組成物 |
JP2007502792A (ja) * | 2003-08-18 | 2007-02-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cgrpアンタゴニスト1−[n2−[3,5−ジブロモ−n−[[4−(3,4−ジヒドロ−2(1h)−オキソキナゾリン−3−イル)−1−ピペリジニル]カルボニル]−d−チロシル]−l−リシル]−4−(4−ピリジニル)−ピペラジンを含有する粉末製剤、その吸入粉末としての製造方法及び使用 |
JP2007502791A (ja) * | 2003-08-18 | 2007-02-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cgrpアンタゴニスト1−〔n2−〔3,5−ジブロモ−n−〔〔4−(3,4−ジヒドロ−2(1h)−オキソキナゾリン−3−イル)−1−ピペリジニル〕カルボニル〕−d−チロシル〕−l−リシル〕−4−(4−ピリジニル)−ピペラジンを含む新規吸入粉末製剤 |
JP2007502789A (ja) * | 2003-08-18 | 2007-02-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 噴霧乾燥された無定形bibn4096、その調製方法及び吸入剤としてのその使用 |
JP2007502790A (ja) * | 2003-08-18 | 2007-02-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cgrpアンタゴニスト1−〔n2−〔3,5−ジブロモ−n−〔〔4−(3,4−ジヒドロ−2(1h)−オキソキナゾリン−3−イル)−1−ピペリジニル〕カルボニル〕−d−チロシル〕−l−リシル〕−4−(4−ピリジニル)−ピペラジンを含む微粒子、その調製方法及び吸入粉末としてのその使用 |
JP2016534063A (ja) * | 2013-10-22 | 2016-11-04 | ザ ジェネラル ホスピタル コーポレイション | クロモリン誘導体ならびに関連するイメージングおよび治療方法 |
US10245331B2 (en) | 2009-01-29 | 2019-04-02 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US10398704B2 (en) | 2012-10-25 | 2019-09-03 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
US10525005B2 (en) | 2013-05-23 | 2020-01-07 | The General Hospital Corporation | Cromolyn compositions and methods thereof |
US10561612B2 (en) | 2017-07-20 | 2020-02-18 | The General Hospital Corporation | Powdered formulations of cromolyn sodium and ibuprofen |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1381872A (en) * | 1971-06-22 | 1975-01-29 | Fisons Ltd | Pharmaceutical compositions for inhalation |
BE787100A (fr) * | 1971-08-06 | 1973-02-02 | Beecham Group Ltd | Composition pour le traitement de l'asthme |
GB1410588A (en) * | 1971-08-10 | 1975-10-22 | Fisons Ltd | Composition |
DE2332663C2 (de) * | 1973-06-23 | 1986-07-31 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie |
DE2535258C2 (de) * | 1974-08-10 | 1993-06-03 | Fisons Plc, Ipswich, Suffolk | Inhalierbares Medikament in Pelletform |
US4161516A (en) * | 1975-07-25 | 1979-07-17 | Fisons Limited | Composition for treating airway disease |
FI770215A (ja) * | 1976-01-30 | 1977-07-31 | Fisons Ltd | |
CY1333A (en) * | 1980-04-30 | 1986-10-24 | Fisons Ltd | Pharmaceutical compositions containing cromoglycates |
BE891013A (fr) * | 1980-11-05 | 1982-05-05 | Fisons Ltd | Compositions pharmaceutique |
JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
JP2770970B2 (ja) * | 1987-04-09 | 1998-07-02 | フアイソンズ・ピーエルシー | ペンタミジンを含有する医薬組成物 |
US5204113A (en) * | 1987-04-09 | 1993-04-20 | Fisons Plc | Pharmaceutical compositions containing pentamidine |
DE4140689B4 (de) * | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalationspulver und Verfahren zu ihrer Herstellung |
EP0606486B1 (en) * | 1992-06-12 | 2001-08-29 | Teijin Limited | Pharmaceutical preparation for intra-airway administration |
US6794357B1 (en) | 1993-06-24 | 2004-09-21 | Astrazeneca Ab | Compositions for inhalation |
US5830853A (en) | 1994-06-23 | 1998-11-03 | Astra Aktiebolag | Systemic administration of a therapeutic preparation |
US6632456B1 (en) | 1993-06-24 | 2003-10-14 | Astrazeneca Ab | Compositions for inhalation |
SG48049A1 (en) * | 1993-10-01 | 1998-04-17 | Astra Ab | Process i |
IS1736B (is) | 1993-10-01 | 1999-12-30 | Astra Ab | Aðferð og tæki sem stuðla að aukinni samloðun agna |
NL9301851A (nl) * | 1993-10-26 | 1995-05-16 | Cordis Europ | Cryo-ablatie catheter. |
GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
GB9404945D0 (en) | 1994-03-15 | 1994-04-27 | Glaxo Group Ltd | Pharmaceutical composition |
US6102036A (en) * | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler |
US6165976A (en) | 1994-06-23 | 2000-12-26 | Astra Aktiebolag | Therapeutic preparation for inhalation |
DE4425255A1 (de) * | 1994-07-16 | 1996-01-18 | Asta Medica Ag | Formulierung zur inhalativen Applikation |
KR100389080B1 (ko) | 1994-12-22 | 2003-10-17 | 아스트라제네카 악티에볼라그 | 부갑상선호르몬(pth)을포함하는흡입용치료제제 |
US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US6648848B1 (en) * | 1997-05-27 | 2003-11-18 | Direct-Haler A/S | Inhaler for powdered medicaments |
PL200940B1 (pl) * | 1998-08-18 | 2009-02-27 | Univ California | Zastosowanie antagonisty receptora naskórkowego czynnika wzrostowego (EGF-R) i postać farmaceutyczna do leczenia nadmiernego wydzielania śluzu dróg oddechowych |
US7354894B2 (en) | 1998-08-18 | 2008-04-08 | The Regents Of The University Of California | Preventing airway mucus production by administration of EGF-R antagonists |
ITMI991582A1 (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
GB9920839D0 (en) | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
EP1129705A1 (en) * | 2000-02-17 | 2001-09-05 | Rijksuniversiteit te Groningen | Powder formulation for inhalation |
PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
GB0009469D0 (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
AU757008B2 (en) * | 2000-10-12 | 2003-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel tiotropium-containing inhalation powder |
UA75375C2 (en) * | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
US20060194773A1 (en) * | 2001-07-13 | 2006-08-31 | Paratek Pharmaceuticals, Inc. | Tetracyline compounds having target therapeutic activities |
DE10141377A1 (de) * | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Aufstreuverfahren zur Herstellung von Pulverformulierungen |
US8337816B2 (en) * | 2001-09-17 | 2012-12-25 | Glaxo Group Limited | Dry powder medicament formulations |
EP1458362A4 (en) * | 2001-11-19 | 2006-01-18 | Becton Dickinson Co | PHARMACEUTICAL COMPOSITIONS IN PARTICLE FORM |
GB0128148D0 (en) | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly |
US6900317B2 (en) * | 2002-02-19 | 2005-05-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them |
US20040014679A1 (en) * | 2002-02-20 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof |
DE10207026A1 (de) * | 2002-02-20 | 2003-08-28 | Boehringer Ingelheim Kg | Pulverinhalativum, enthaltend den CGRP-Antagonisten BIBN4096 und Verfahren zu dessen Herstellung |
DE10255387A1 (de) * | 2002-11-28 | 2004-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Tiotropium-haltige Pulverformulierung für die Inhalation |
US7763280B2 (en) * | 2002-11-28 | 2010-07-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation |
DE10317461A1 (de) | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung |
US20050042178A1 (en) * | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder |
US20050042179A1 (en) * | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine |
US20050043247A1 (en) * | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative |
US9345664B2 (en) | 2003-09-02 | 2016-05-24 | Norton Healthcare Ltd | Process for preparing a medicament |
PE20050489A1 (es) | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
WO2005102429A1 (en) | 2004-04-21 | 2005-11-03 | Innovata Biomed Limited | Inhaler |
GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
PE20060259A1 (es) | 2004-04-27 | 2006-03-25 | Glaxo Group Ltd | Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico |
US7723306B2 (en) * | 2004-05-10 | 2010-05-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation |
US7611709B2 (en) * | 2004-05-10 | 2009-11-03 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
US7727962B2 (en) * | 2004-05-10 | 2010-06-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder comprising new compositions of oligosaccharides and methods for their preparation |
DE102004048389A1 (de) * | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa |
DE102004048390A1 (de) * | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff |
CN104177448A (zh) | 2005-02-10 | 2014-12-03 | 葛兰素集团有限公司 | 使用预分选技术制备乳糖的方法以及由此形成的药物制剂 |
WO2010010538A2 (en) | 2008-07-24 | 2010-01-28 | L'air Liquide-Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Heteroleptic cyclopentadienyl transition metal precursors for deposition of transition metal-containing films |
ES2739352T3 (es) | 2009-02-26 | 2020-01-30 | Glaxo Group Ltd | Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
PT106094A (pt) | 2012-01-13 | 2013-07-15 | Hovione Farmaciencia S A | Administração por inalação de formulações com dose elevada |
US20150165038A1 (en) * | 2012-02-10 | 2015-06-18 | Arven llac Sanayi Ve Ticaret A.S. | Compositions comprising muscarinic receptor antagonist and sorbitol |
WO2014007769A1 (en) * | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Compositions comprising muscarinic receptor antagonist and glucose anhydrous |
WO2014007772A2 (en) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions comprising glucose anhydrous |
WO2014007771A2 (en) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions comprising muscarinic receptor antagonist |
GB201305825D0 (en) | 2013-03-28 | 2013-05-15 | Vectura Ltd | New use |
US10307370B2 (en) | 2013-10-08 | 2019-06-04 | AI Therapeutics, Inc. | Rapamycin for the treatment of lymphangioleiomyomatosis |
HUE062742T2 (hu) | 2014-04-04 | 2023-12-28 | Ai Therapeutics Inc | Belélegezhetõ rapamicin készítmény életkorral kapcsolatos állapotok kezelésére |
MX2017004440A (es) | 2014-10-07 | 2017-11-01 | Lam Therapeutics Inc | Una formulacion de rapamicina inhalable para el tratamiento de hipertension pulmonar. |
JP2019524865A (ja) | 2016-08-31 | 2019-09-05 | ザ ジェネラル ホスピタル コーポレイション | 神経変性疾患と関連する神経炎症におけるマクロファージ/ミクログリア |
UA126238C2 (uk) * | 2017-06-28 | 2022-09-07 | Філіп Морріс Продактс С.А. | Ємність з частинками для використання з інгалятором |
AU2019299347A1 (en) | 2018-07-02 | 2021-01-21 | Aztherapies, Inc. | Powdered formulations of cromolyn sodium and alpha-lactose |
WO2020031119A1 (en) | 2018-08-07 | 2020-02-13 | Norton (Waterford) Limited | Application of raman spectroscopy for the manufacture of inhalation powders |
WO2022043481A1 (en) | 2020-08-28 | 2022-03-03 | Universität Linz | Use of leoligin in the prevention of tissue damage |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1792207U (de) | 1959-04-14 | 1959-07-16 | Esslinger Sack Und Planenfabri | Transportables gartenschwimm- oder -planschbecken mit aus kunststoff-folie bestehenden waenden. |
FR1489749A (fr) * | 1965-03-25 | 1967-07-28 | Fisons Pharmaceuticals Ltd | Procédé de préparation de composés bis-chromonylés et leurs dérivés |
-
1967
- 1967-08-08 GB GB36270/67A patent/GB1242211A/en not_active Expired
-
1968
- 1968-07-25 IE IE898/68A patent/IE32343B1/xx unknown
- 1968-07-30 FI FI682158A patent/FI48973C/fi active
- 1968-07-31 US US748937A patent/US3634582A/en not_active Expired - Lifetime
- 1968-07-31 BE BE718846D patent/BE718846A/xx not_active IP Right Cessation
- 1968-08-01 CA CA026,437A patent/CA946280A/en not_active Expired
- 1968-08-02 NL NL6811060.A patent/NL161984C/xx not_active IP Right Cessation
- 1968-08-03 DE DE1792207A patent/DE1792207C3/de not_active Expired
- 1968-08-03 DE DE19681792799 patent/DE1792799A1/de not_active Ceased
- 1968-08-07 NO NO03102/68A patent/NO128307B/no unknown
- 1968-08-07 FR FR162134A patent/FR8142M/fr not_active Expired
- 1968-08-07 SE SE6810634A patent/SE372420B/xx unknown
- 1968-08-07 DK DK380968AA patent/DK123276B/da unknown
- 1968-08-21 FR FR163601A patent/FR1605538A/fr not_active Expired
-
1971
- 1971-04-14 JP JP2321371A patent/JPS5643448B1/ja active Pending
-
1974
- 1974-12-30 MY MY329/74A patent/MY7400329A/xx unknown
- 1974-12-30 MY MY330/74A patent/MY7400330A/xx unknown
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006516531A (ja) * | 2002-08-21 | 2006-07-06 | ノートン ヘルスケアー リミテッド | 吸入組成物 |
JP2007502792A (ja) * | 2003-08-18 | 2007-02-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cgrpアンタゴニスト1−[n2−[3,5−ジブロモ−n−[[4−(3,4−ジヒドロ−2(1h)−オキソキナゾリン−3−イル)−1−ピペリジニル]カルボニル]−d−チロシル]−l−リシル]−4−(4−ピリジニル)−ピペラジンを含有する粉末製剤、その吸入粉末としての製造方法及び使用 |
JP2007502791A (ja) * | 2003-08-18 | 2007-02-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cgrpアンタゴニスト1−〔n2−〔3,5−ジブロモ−n−〔〔4−(3,4−ジヒドロ−2(1h)−オキソキナゾリン−3−イル)−1−ピペリジニル〕カルボニル〕−d−チロシル〕−l−リシル〕−4−(4−ピリジニル)−ピペラジンを含む新規吸入粉末製剤 |
JP2007502789A (ja) * | 2003-08-18 | 2007-02-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 噴霧乾燥された無定形bibn4096、その調製方法及び吸入剤としてのその使用 |
JP2007502790A (ja) * | 2003-08-18 | 2007-02-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cgrpアンタゴニスト1−〔n2−〔3,5−ジブロモ−n−〔〔4−(3,4−ジヒドロ−2(1h)−オキソキナゾリン−3−イル)−1−ピペリジニル〕カルボニル〕−d−チロシル〕−l−リシル〕−4−(4−ピリジニル)−ピペラジンを含む微粒子、その調製方法及び吸入粉末としてのその使用 |
US10251961B2 (en) | 2009-01-29 | 2019-04-09 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US10245331B2 (en) | 2009-01-29 | 2019-04-02 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US10576171B2 (en) | 2009-01-29 | 2020-03-03 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US11801316B2 (en) | 2009-01-29 | 2023-10-31 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US10398704B2 (en) | 2012-10-25 | 2019-09-03 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
US10406164B2 (en) | 2012-10-25 | 2019-09-10 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
US10413551B2 (en) | 2012-10-25 | 2019-09-17 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer'S disease and related disorders |
US10525005B2 (en) | 2013-05-23 | 2020-01-07 | The General Hospital Corporation | Cromolyn compositions and methods thereof |
US11013686B2 (en) | 2013-05-23 | 2021-05-25 | The General Hospital Corporation | Cromolyn compositions and methods thereof |
US10188757B2 (en) | 2013-10-22 | 2019-01-29 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
JP2016534063A (ja) * | 2013-10-22 | 2016-11-04 | ザ ジェネラル ホスピタル コーポレイション | クロモリン誘導体ならびに関連するイメージングおよび治療方法 |
US11666669B2 (en) | 2013-10-22 | 2023-06-06 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US10561612B2 (en) | 2017-07-20 | 2020-02-18 | The General Hospital Corporation | Powdered formulations of cromolyn sodium and ibuprofen |
Also Published As
Publication number | Publication date |
---|---|
FI48973B (ja) | 1974-12-02 |
FR8142M (ja) | 1970-08-17 |
FR1605538A (ja) | 1979-02-23 |
CA946280A (en) | 1974-04-30 |
NO128307B (ja) | 1973-10-29 |
SE372420B (ja) | 1974-12-23 |
DE1792799A1 (de) | 1977-08-11 |
IE32343B1 (en) | 1973-06-27 |
NL161984B (nl) | 1979-11-15 |
FI48973C (fi) | 1975-03-10 |
MY7400329A (en) | 1974-12-31 |
IE32343L (en) | 1969-02-08 |
DK123276B (da) | 1972-06-05 |
MY7400330A (en) | 1974-12-31 |
GB1242211A (en) | 1971-08-11 |
US3634582A (en) | 1972-01-11 |
NL161984C (nl) | 1980-04-15 |
DE1792207B2 (de) | 1977-10-13 |
DE1792207C3 (de) | 1978-06-29 |
BE718846A (ja) | 1969-01-31 |
DE1792207A1 (de) | 1971-11-04 |
NL6811060A (ja) | 1969-02-11 |